• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • Latest
  • Videos
  • Series
  • E-Newsletters
    • Fat Tail Daily
    • James Cooper’s Mining Memo
    • The Daily Reckoning Australia
  • Categories
    • Commodities
    • Macro
    • Market Analysis
    • Small Caps
    • Technology
  • Investment Guides
  • Premium Services
  • Editors
  • About
  • Contact Us
Fat Tail Daily
Subscribe
  • Home
  • Latest
  • Videos
  • E-Newsletters
  • Premium Services
Latest ASX News

Nearmap Share Price Stumbles on ASX Query Response (ASX:NEA)

Like 0

By Lachlann Tierney, Monday, 17 May 2021

The Nearmap [ASX:NEA] today responded to the ASX’s price query regarding legal proceedings launched against it by US rival, sending NEA share price down...

The Nearmap Ltd [ASX:NEA] today responded to the ASX’s price query regarding legal proceedings launched against it by US rival, sending NEA share price down.

At the time of writing, Nearmap’s share price was down 2.6%, continuing a slide precipitated by an intellectual property infringement complaint lodged by the company’s US rival EagleView.

We covered the initial story here.

The looming legal proceedings sent NEA shares falling 23% this month, with the aerial imagery firm well off its 52-week high of $3.22.

ASX NEA - Nearmap Share Price ChartSource: Tradingview.com

ASX seeks answers from Nearmap

On 13 May, the ASX issued Nearmap a general query notice regarding NEA’s 6 May announcement about a complaint lodged against it in the United States District court of Utah.

Among several questions, the ASX wished to know whether NEA’s disclosure of the upcoming litigation is information a reasonable person would expect to have a material effect on Nearmap’s share price or value.

In response, NEA admitted that information concerning EagleView’s patent infringement claim ‘could have a material effect on the price or value’ of NEA’s securities.

Nearmap revealed that it formed this view after an initial assessment on 5 May, surmising that the information ‘could potentially be material to the market price of NEA shares.’

What is interesting is that while Nearmap held this view on 5 May, its public announcement the following day emphatically stated that:

‘The allegations do not affect Nearmap’s core proprietary technology and do not affect the surveying of imagery or the delivery of premium content. The business remains unaffected.’

The claim that NEA’s business remains unaffected could be in tension with NEA’s later claim made to the ASX that EagleView’s lawsuit could materially affect the value — and not just the price — of NEA’s securities.

Nearmap also divulged today that its announcement to the market on 6 May was preceded by a Board update and the creation of a subcommittee specifically convened to approve the messaging of the release.

This subcommittee was satisfied the 6 May announcement was ‘accurate, complete, and not misleading.’

Outlook for the Nearmap Share Price

As I covered last week, the upcoming patent infringement court case facing Nearmap gave short seller J Capital the opportunity to reiterate its pessimistic stance on NEA’s business prospects in the US market.

J Capital’s research suggested that if EagleView’s court challenge succeeds, Nearmap ‘may be required to pay a royalty to EagleView, find a different way to do a map, or stop producing roof measurements and roof reports altogether in the US.’

This could undercut Nearmap’s claim its core business would remain unaffected as J Capital estimated 41% of NEA’s US sales come from roof reports for the insurance sector, which uses them to assess damages claims.

Nonetheless, the legal cloud over Nearmap did not stop Morgan Stanley from retaining an overweight recommendation for NEA shares, with a target price of $3.20.

The investment bank thought NEA’s current price discounts the company’s US business, despite EagleView’s lawsuit:

‘On a [sum-of-the-parts] basis, we value Nearmap’s Australia and New Zealand business at $666 million … the enterprise value is $740 million, implying a modest $74 million for the North American business.

‘Even assuming a bearish legal outcome affecting both regions’ operating performance, plus a significant cash outflow for damages (unspecified claim to date), the current price still implies a much lower value for NA vs ANZ despite a similar revenue base, higher growth, and superior economics.’

The market wasn’t reassured by Nearmap’s response to the ASX, with the stock trading slightly lower today.

It seems investors remain uncertain about the strength of EagleView’s legal challenge and its impact on Nearmap’s US sales.

And with the likes of J Capital and Morgan Stanley offering diverging appraisals of Nearmap’s prospects, the uncertainty is likely compounded.

So if you’re put off by this uncertainty, but remain interested in stocks at the forefront of technological advancements, then I recommend reading our free AI stocks report.

It details why the AI boom could accelerate in 2021 and outlines five high-potential stocks to watch. Download your free report now.

Regards,

Lachlann Tierney,

For Money Morning

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Comments

Subscribe
Notify of
guest
guest
0 Comments
Lachlann Tierney
Lachlann ‘Lachy’ Tierney is passionate about uncovering hidden opportunities in the microcap sector. With four years of experience as a senior equities analyst at one of Australia’s leading microcap firms, he has built a reputation for rigorous research, deep-dive due diligence, and accessible investor communications. Over this time, he has vetted seed, pre-IPO and ASX-listed companies across sectors, conducted onsite visits, and built strong relationships across the microcap space. Lachy holds a PhD in economics from RMIT University, where his research focused on blockchain governance and voting systems. His work was housed within the Blockchain Innovation Hub at RMIT, a leading research centre for crypto-economics and blockchain research. He also holds a Master of Science degree from the London School of Economics and an B.A. (Hons.) in Philosophy and Politics from the University of Melbourne. Born in New York and raised in California, Lachy grew up a few blocks from biotech giant Amgen and counts among his peers various characters in the overlapping worlds of venture capital, technology and crypto. When he’s not researching microcaps, he’s most likely sweating it out in a sauna or dunking himself in cold Tasmanian water.

Lachlann’s Premium Subscriptions

Publication logo
Australian Small-Cap Investigator
Publication logo
Fat Tail Microcaps
Publication logo
James Altucher’s Early-Stage Crypto Investor Australia

Latest Articles

  • Selling the Signal
    By Charlie Ormond

    Trading firms can now pay the President’s company for millisecond access to the President’s posts. Most companies have to make a product. This one just makes news.

  • Greg Canavan Chats Markets on Closing Bell
    By Charlie Ormond

    This week, Greg Canavan joins Charlie to discuss the direction of the ASX, the valuations of some of our biggest players, China’s recent growth hiccups, and what they mean for our local commodity producers.

  • Speculation Fades: Gold Accumulation Begins
    By James Cooper

    Gold’s wildest year on record delivered panic, war, and a 20% crash — but the real story is just beginning.

Primary Sidebar

Latest Articles

  • Selling the Signal
  • Greg Canavan Chats Markets on Closing Bell
  • Speculation Fades: Gold Accumulation Begins
  • Canberra’s Cover Charge
  • The Lunch That Changed Everything

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988